Bellerophon Therapeutics Inc
NASDAQ:BLPH
Bellerophon Therapeutics Inc
NASDAQ:BLPH
Price:
0.06 USD
6.01%
Market Closed
Updated:
Jun 1, 2024
Bellerophon Therapeutics Inc
Retained Earnings
|
Bellerophon Therapeutics Inc
Retained Earnings Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bellerophon Therapeutics Inc
NASDAQ:BLPH
|
Retained Earnings
-$256.3m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Retained Earnings
$15.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Retained Earnings
$1.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Retained Earnings
$17.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Retained Earnings
$38B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Retained Earnings
$5.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
24%
|
CAGR 10-Years
17%
|
See Also
What is Bellerophon Therapeutics Inc's Retained Earnings?
Retained Earnings
-256.3m
USD
-256.3m
USD
Based on the financial report for Sep 30, 2023, Bellerophon Therapeutics Inc's Retained Earnings amounts to -256.3m USD.
What is Bellerophon Therapeutics Inc's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-8%
-8%
Over the last year, the Retained Earnings growth was -4%. The average annual Retained Earnings growth rates for Bellerophon Therapeutics Inc have been -7% over the past three years , -8% over the past five years .
You don't have any saved screeners yet
